Last reviewed · How we verify
MINIRIN Oral Lyophilisate
MINIRIN Oral Lyophilisate is a Small molecule drug developed by Ferring Pharmaceuticals. It is currently FDA-approved.
MINIRIN Oral Lyophilisate, marketed by Ferring Pharmaceuticals, is an established product with a key composition patent expiring in 2028. The drug's primary strength lies in its current market presence, leveraging Ferring's strong commercial infrastructure. The primary risk is the potential increase in competition post-patent expiry in 2028.
At a glance
| Generic name | MINIRIN Oral Lyophilisate |
|---|---|
| Sponsor | Ferring Pharmaceuticals |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study (PHASE4)
- Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population (PHASE4)
- Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia (PHASE3)
- Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study (PHASE4)
- Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo (PHASE2)
- Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis (PHASE3)
- A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MINIRIN Oral Lyophilisate CI brief — competitive landscape report
- MINIRIN Oral Lyophilisate updates RSS · CI watch RSS
- Ferring Pharmaceuticals portfolio CI
Frequently asked questions about MINIRIN Oral Lyophilisate
What is MINIRIN Oral Lyophilisate?
Who makes MINIRIN Oral Lyophilisate?
What development phase is MINIRIN Oral Lyophilisate in?
Related
- Manufacturer: Ferring Pharmaceuticals — full pipeline
- Compare: MINIRIN Oral Lyophilisate vs similar drugs
- Pricing: MINIRIN Oral Lyophilisate cost, discount & access